Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P[v-a]CO2-guided hemodynamic management in thoracoscopic lobectomy
ChiCTR2500098400Phase 3Recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of hetastarch and norepinephrine in bronchial carcinoma (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Postoperative recovery quality. Started Mar 2025; status: recruiting.
02
Drugs
hetastarchnorepinephrine
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR2500098400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098400.